CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Mylan Laboratories's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 2, 2019Stabilized Transdermal Drug Delivery System1
Jan 10, 2018Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof2

Top competitors of Mylan Laboratories

List of top competitors of Mylan Laboratories based on patent oppositions.